Targeting endoplasmic reticulum stress pathways to treat neurological disorders associated with protein misfolding

Protein Misfolding Disorders: A Trip into the ER

Volumn , Issue , 2009, Pages 1-8

  Galleguillos, Danny ^a   Matus, Soledad ^b   Valenzuela, Vicente ^b   Valdés, Pamela ^b   Martínez, Alexis ^b   Nassif, Melissa ^b   Torres, Mauricio ^b   Martínez, Gabriela ^b   Hetz, Claudio ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 83655174780     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805013010901010001     Document Type: Chapter

References (141)

1. Kopito, R.R., Ron, D. Conformational disease. Nat Cell Biol, 2000; 2(11): E207-209.
2. Rao, R.V., Bredesen, D.E. Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr Opin Cell Biol, 2004; 16(6): 653-662.
3. Selkoe, D. J. Folding proteins in fatal ways. Nature, 2003; 426(6968): 900-904.
4. Taylor, J.P., Hardy, J., Fischbeck, K.H. Toxic proteins in neurodegenerative disease. Science, 2002; 296(5575): 1991-1995.
5. Ron, D., Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol, 2007; 8(7): 519-529.
6. Schroder, M., Kaufman, R.J. The mammalian unfolded protein response. Annu Rev Biochem, 2005; 74(739-789.
7. Hetz, C. A., Torres, V., Quest, A. F. Beyond apoptosis: nonapoptotic cell death in physiology and disease. Biochem Cell Biol, 2005; 83(5): 579-588.
8. Hetz, C., Glimcher, L. XBP-1 and the UPRosome: Mastering secretory cell function. Curr Immunol Rev, 2008; In Press.
9. Harding, H. P., Zhang, Y., Ron, D. Protein translation and folding are coupled by an endoplasmic-reticulumresident kinase. Nature, 1999; 397(6716): 271-274.
10. Chen, X., Shen, J., Prywes, R. The luminal domain of ATF6 senses endoplasmic reticulum (ER) stress and causes translocation of ATF6 from the ER to the Golgi. J Biol Chem, 2002; 277(15): 13045-13052.
11. Haze, K., Yoshida, H., Yanagi, H., Yura, T., Mori, K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell, 1999; 10(11): 3787-3799.
12. Ye, J., Rawson, R.B., Komuro, R., Chen, X., Dave, U.P., Prywes, R., Brown, M.S., Goldstein, J.L. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell, 2000; 6(6): 1355-1364.
13. Lee, K., Tirasophon, W., Shen, X., Michalak, M., Prywes, R., Okada, T., Yoshida, H., Mori, K., Kaufman, R. J. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev, 2002; 16(4): 452-466.
14. Calfon, M., Zeng, H., Urano, F., Till, J.H., Hubbard, S.R., Harding, H.P., Clark, S.G., Ron, D. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature, 2002; 415(6867): 92-96.
15. Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell, 2001; 107(7): 881-891.
16. Hetz, C., Glimcher, L. The daily job of night killers: alternative roles of the BCL-2 family in organelle physiology. Trends Cell Biol, 2008; 18(1): 38-44.
17. Hetz, C., Bernasconi, P., Fisher, J., Lee, A. H., Bassik, M. C., Antonsson, B., Brandt, G. S., Iwakoshi, N.N., Schinzel, A., Glimcher, L.H., Korsmeyer, S.J. Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha. Science, 2006; 312(5773): 572-576.
18. Hoozemans, J.J., van Haastert, E.S., Eikelenboom, P., de Vos, R.A., Rozemuller, J.M., Scheper, W. Activation of the unfolded protein response in Parkinson's disease. Biochem Biophys Res Commun, 2007; 354(3): 707-711.
19. Uehara, T., Nakamura, T., Yao, D., Shi, Z.Q., Gu, Z., Ma, Y., Masliah, E., Nomura, Y., Lipton, S.A. Snitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature, 2006; 441(7092): 513-517.
20. Conn, K.J., Gao, W., McKee, A., Lan, M.S., Ullman, M.D., Eisenhauer, P.B., Fine, R.E., Wells, J. M. Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology. Brain Res, 2004; 1022(1-2): 164-172.
21. Ilieva, E.V., Ayala, V., Jove, M., Dalfo, E., Cacabelos, D., Povedano, M., Bellmunt, M.J., Ferrer, I., Pamplona, R., Portero-Otin, M. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain, 2007; 130(Pt 12): 3111-3123.
22. Atkin, J. D., Farg, M.A., Walker, A.K., McLean, C., Tomas, D., Horne, M.K. Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol Dis, 2008; 30(3): 400-407.
23. Unterberger, U., Hoftberger, R., Gelpi, E., Flicker, H., Budka, H., Voigtlander, T. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J Neuropathol Exp Neurol, 2006; 65(4): 348-357.
24. Hetz, C., Russelakis-Carneiro, M., Maundrell, K., Castilla, J., Soto, C. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. Embo J, 2003; 22(20): 5435-5445.
25. Yoo, B.C., Krapfenbauer, K., Cairns, N., Belay, G.,Bajo, M., Lubec, G. Overexpressed protein disulfide isomerase in brains of patients with sporadic Creutzfeldt-Jakob disease. Neurosci Lett, 2002; 334(3):196-200.
26. Lindholm, D., Wootz, H., Korhonen, L. ER stress and neurodegenerative diseases. Cell Death Differ, 2006; 13(3): 385-392.
27. Matus, S., Lisbona, F., Torres, M., Leon, C., Thielen, P., Hetz, C. The stress rheostat: an interplay between the unfolded protein response (UPR) and autophagy in neurodegeneration. Curr Mol Med, 2008; 8(3): 157- 172.
28. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell, 1993; 72(6): 971-983.
29. Kremer, B., Goldberg, P., Andrew, S. E., Theilmann, J., Telenius, H., Zeisler, J., Squitieri, F., Lin, B., Bassett, A., Almqvist, E., et al. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med, 1994; 330(20): 1401-1406.
30. Rubinsztein, D. C. Lessons from animal models of Huntington's disease. Trends Genet, 2002; 18(4): 202- 209.
31. Hackam, A. S., Singaraja, R., Wellington, C. L., Metzler, M., McCutcheon, K., Zhang, T., Kalchman, M., Hayden, M. R. The influence of huntingtin proteinsize on nuclear localization and cellular toxicity. J Cell Biol, 1998; 141(5): 1097-1105.
32. Lunkes, A., Mandel, J. L. A cellular model that recapitulates major pathogenic steps of Huntington's disease. Hum Mol Genet, 1998; 7(9): 1355-1361
33. Wyttenbach, A., Carmichael, J., Swartz, J., Furlong, R. A., Narain, Y., Rankin, J., Rubinsztein, D. C. Effects of heat shock, heat shock protein 40 (HDJ-2), andproteasome inhibition on protein aggregation in cellular models of Huntington's disease. Proc Natl Acad Sci U S A, 2000; 97(6): 2898-2903.
34. Nucifora, F. C., Jr., Sasaki, M., Peters, M.F., Huang, H., Cooper, J.K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V.L., Dawson, T.M., Ross, C.A. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science, 2001; 291(5512): 2423-2428.
35. Ravikumar, B., Rubinsztein, D.C.,Role of autophagy in the clearance of mutant huntingtin: a step towards therapy? Mol Aspects Med, 2006; 27(5-6): 520-527.
36. Momoi, T. Conformational diseases and ER stressmediated cell death: apoptotic cell death and autophagic cell death. Curr Mol Med, 2006; 6(1): 111- 118.
37. Kopito, R. R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol, 2000; 10(12): 524-530.
38. Omi, K., Hachiya, N. S., Tokunaga, K., Kaneko, K. siRNA-mediated inhibition of endogenous Huntington disease gene expression induces an aberrant configuration of the ER network in vitro. Biochem Biophys Res Commun, 2005; 338(2): 1229-1235.
39. Strehlow, A.N., Li, J.Z., Myers, R.M. Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space. Hum Mol Genet, 2007; 16(4): 391-409.
40. del Toro, D., Canals, J. M., Gines, S., Kojima, M., Egea, G., Alberch, J. Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism. J Neurosci, 2006; 26(49): 12748-12757.
41. Rockabrand, E., Slepko, N., Pantalone, A., Nukala, V.N., Kazantsev, A., Marsh, J.L., Sullivan, P.G., Steffan, J. S., Sensi, S. L., Thompson, L. M. The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet, 2007; 16(1): 61-77
42. Rousseau, E., Dehay, B., Ben-Haiem, L., Trottier, Y., Morange, M., Bertolotti, A. Targeting expression of expanded polyglutamine proteins to the endoplasmic reticulum or mitochondria prevents their aggregation. Proc Natl Acad Sci U S A, 2004; 101(26): 9648-9653.
43. Kouroku, Y., Fujita, E., Tanida, I., Ueno, T., Isoai, A. ,Kumagai, H., Ogawa, S., Kaufman, R.J., Kominami, E., Momoi, T. ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ, 2007; 14(2): 230-239.
44. Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., Yuan, J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature, 2000; 403(6765):98-103.
45. Nishitoh, H., Matsuzawa, A., Tobiume, K., Saegusa,K., Takeda, K., Inoue, K., Hori, S., Kakizuka, A., Ichijo, H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev, 2002; 16(11): 1345-1355.
46. Jana, N. R., Tanaka, M., Wang, G., Nukina, N. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated Nterminal huntingtin: their role in suppression of aggregation and cellular toxicity. Hum Mol Genet, 2000; 9(13): 2009-2018.
47. Maiuri, M. C., Zalckvar, E., Kimchi, A., Kroemer, G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol, 2007; 8(9): 741-752.
48. Ozcan, U., Yilmaz, E., Ozcan, L., Furuhashi, M., Vaillancourt, E., Smith, R.O., Gorgun, C.Z.,Hotamisligil, G. S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science, 2006; 313(5790): 1137-1140.
49. Welch, W.J., Brown, C. R. Influence of molecular andchemical chaperones on protein folding. Cell StressChaperones, 1996; 1(2): 109-115.
50. Xie, Q., Khaoustov, V.I., Chung, C.C., Sohn, J.,Krishnan, B., Lewis, D.E., Yoffe, B. Effect ofstress-induced caspase-12 activation. Hepatology,2002; 36(3): 592-601.
51. Keene, C.D., Rodrigues, C. M., Eich, T., Chhabra, M.S., Steer, C.J., Low, W.C. Tauroursodeoxycholic acid,a bile acid, is neuroprotective in a transgenic animalmodel of Huntington's disease. Proc Natl Acad Sci U S52. Gardian, G., Browne, S. E., Choi, D. K., Klivenyi, P.,Gregorio, J., Kubilus, J. K., Ryu, H., Langley, B.,Ratan, R. R., Ferrante, R. J., Beal, M. F.Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem, 2005; 280(1): 556-563.
52. Hoyer-Hansen, M., Jaattela, M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ, 2007; 14(9): 1576-1582.
53. Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., Tanaka, K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature, 2006; 441(7095): 880-884.
54. Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., Mizushima, N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature, 2006; 441(7095): 885-889.
55. Ravikumar, B., Rubinsztein, D. C. Can autophagy protect against neurodegeneration caused by aggregateprone proteins? Neuroreport, 2004; 15(16): 2443-2445.
56. Floto, R.A., Sarkar, S., Perlstein, E.O., Kampmann, B., Schreiber, S.L., Rubinsztein, D.C. Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages. Autophagy, 2007; 3(6): 620-622.
57. Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A., Rubinsztein, D. C. Trehalose, a novel mTORindependent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem, 2007; 282(8): 5641-5652.
58. Sarkar, S., Perlstein, E.O., Imarisio, S., Pineau, S., Cordenier, A., Maglathlin, R.L., Webster, J.A., Lewis, T.A., O'Kane, C.J., Schreiber, S.L., Rubinsztein, D. C. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat ChemBiol, 2007; 3(6): 331-338.
59. Boillee, S., Vande Velde, C., Cleveland, D. W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 2006; 52(1): 39-59.
60. Pasinelli, P., Brown, R. H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci, 2006; 7(9): 710-723.
61. Turner, B.J., Atkin, J.D. ER stress and UPR in familial amyotrophic lateral sclerosis. Curr Mol Med, 2006; 6(1): 79-86.
62. Gonatas, N.K., Stieber, A., Gonatas, J.O. Fragmentation of the Golgi apparatus inneurodegenerative diseases and cell death. J Neurol Sci, 2006; 246(1-2): 21-30.
63. Vlug, A.S., Teuling, E., Haasdijk, E.D., French, P., Hoogenraad, C.C., Jaarsma, D. ATF3 expression precedes death of spinal motoneurons in amyotrophic lateral sclerosis-SOD1 transgenic mice and correlates with c-Jun phosphorylation, CHOP expression, somato-dendritic ubiquitination and Golgi fragmentation. Eur J Neurosci, 2005; 22(8): 1881- 1894.
64. Nagata, T., Ilieva, H., Murakami, T., Shiote, M., Narai, H., Ohta, Y., Hayashi, T., Shoji, M., Abe, K. Increased ER stress during motor neuron degeneration in a transgenic mouse model of amyotrophic lateral sclerosis. Neurol Res, 2007; 29(8): 767-771.
65. Kikuchi, H., Almer, G., Yamashita, S., Guegan, C., Nagai, M., Xu, Z., Sosunov, A. A., McKhann, G. M., 2nd, Przedborski, S. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc Natl Acad Sci U S A, 2006; 103(15): 6025-6030.
66. Wootz, H., Hansson, I., Korhonen, L., Napankangas, U., Lindholm, D. Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALS. Biochem Biophys Res Commun, 2004; 322(1): 281-286.
67. Atkin, J.D., Farg, M.A., Turner, B.J., Tomas, D., Lysaght, J.A., Nunan, J., Rembach, A., Nagley, P., Beart, P.M., Cheema, S.S., Horne, M.K. Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. J Biol Chem, 2006; 281(40): 30152-30165.
68. Urushitani, M., Sik, A., Sakurai, T., Nukina, N.,Takahashi, R., Julien, J. P. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci, 2006; 9(1): 108-118.
69. Wootz, H., Hansson, I., Korhonen, L., Lindholm, D. XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice. Exp Cell Res, 2006; 312(10): 1890-1898.
70. Kieran, D., Woods, I., Villunger, A., Strasser, A., Prehn, J.H. Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice. Proc Natl Acad Sci U S A, 2007; 104(51): 20606- 20611.
71. Urushitani, M., Ezzi, S. A., Matsuo, A., Tooyama, I., Julien, J.P. The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. Faseb J, 2008; 22(7): 2476-2487.
72. Morishima, N., Nakanishi, K., Tsuchiya, K., Shibata, T., Seiwa, E. Translocation of Bim to the endoplasmic reticulum (ER) mediates ER stress signaling for activation of caspase-12 during ER stress-induced apoptosis. J Biol Chem, 2004; 279(48): 50375-50381.
73. Puthalakath, H., O'Reilly, L. A., Gunn, P., Lee, L.,Kelly, P. N., Huntington, N.D., Hughes, P.D., Michalak, E.M., McKimm-Breschkin, J., Motoyama, N., Gotoh, T., Akira, S., Bouillet, P., Strasser, A. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell, 2007; 129(7): 1337-1349.
74. Hetz, C., Thielen, P., Fisher, J., Pasinelli, P., Brown, R. H., Korsmeyer, S., Glimcher, L. The proapoptotic BCL-2 family member BIM mediates motoneuron lossin a model of amyotrophic lateral sclerosis. Cell Death Differ, 2007; 14(7): 1386-1389.
75. Tsuda, H., Han, S. M., Yang, Y., Tong, C., Lin, Y.Q., Mohan, K., Haueter, C., Zoghbi, A., Harati, Y., Kwan, J., Miller, M.A., Bellen, H.J. The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell, 2008; 133(6): 963- 977.
76. Gkogkas, C., Middleton, S., Kremer, A.M., Wardrope,C., Hannah, M., Gillingwater, T.H., Skehel, P. VAPBinteracts with and modulates the activity of ATF6.Hum Mol Genet, 2008; 17(11): 1517-1526
77. Teuling, E., Ahmed, S., Haasdijk, E., Demmers, J.,Steinmetz, M. O., Akhmanova, A., Jaarsma, D., Hoogenraad, C. C. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J Neurosci, 2007; 27(36): 9801-9815.
78. Boyce, M., Bryant, K. F., Jousse, C., Long, K., Harding, H.P., Scheuner, D., Kaufman, R.J., Ma, D., Coen, D.M., Ron, D., Yuan, J. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ERstress. Science, 2005; 307(5711): 935-939.
79. Oh, Y.K., Shin, K.S., Yuan, J., Kang, S.J. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells. J Neurochem, 2008; 104(4): 993-1005.
80. Ohta, Y., Kamiya, T., Nagai, M., Nagata, T., Morimoto, N., Miyazaki, K., Murakami, T., Kurata, T., Takehisa, Y., Ikeda, Y., Asoh, S., Ohta, S., Abe, K. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis. J Neurosci Res, 2008; 86(13): 3028-3037.
81. Nishitoh, H., Kadowaki, H., Nagai, A., Maruyama, T., Yokota, T., Fukutomi, H., Noguchi, T., Matsuzawa, A., Takeda, K., Ichijo, H. ALS-linked mutant SOD1\ induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev, 2008; 22(11): 1451-1464.
82. Raoul, C., Abbas-Terki, T., Bensadoun, J.C., Guillot, S., Haase, G., Szulc, J., Henderson, C.E., Aebischer, P. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med, 2005; 11(4): 423- 428.
83. Azzouz, M., Hottinger, A., Paterna, J.C., Zurn, A. D.,Aebischer, P., Bueler, H. Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2. Hum Mol Genet, 2000; 9(5): 803-811.
84. Kirik, D., Bjorklund, A. Modeling CNS neurodegeneration by overexpression of diseasecausing proteins using viral vectors. Trends Neurosci, 2003; 26(7): 386-392.
85. Azzouz, M., Kingsman, S. M., Mazarakis, N. D. Lentiviral vectors for treating and modeling human CNS disorders. J Gene Med, 2004; 6(9): 951-962.8787. Petri, S., Kiaei, M., Kipiani, K., Chen, J., Calingasan,
86. Petri, S., Kiaei, M., Kipiani, K., Chen, J., Calingasan, Kabuta, T., Suzuki, Y., Wada, K.Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis, 2006; 22(1): 40-49.
87. Kabuta, T., Suzuki, Y., Wada, K. Degradation of amyotrophic lateral sclerosis-linked mutant Cu,Znsuperoxide dismutase proteins by macroautophagy and the proteasome. J Biol Chem, 2006; 281(41): 30524- 30533.
88. Morimoto, N., Nagai, M., Ohta, Y., Miyazaki, K., Kurata, T., Morimoto, M., Murakami, T., Takehisa, Y., Ikeda, Y., Kamiya, T., Abe, K. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res, 2007; 1167(112-117.
89. Fornai, F., Longone, P., Cafaro, L., Kastsiuchenka, O., Ferrucci, M., Manca, M.L., Lazzeri, G., Spalloni, A., Bellio, N., Lenzi, P., Modugno, N., Siciliano, G., Isidoro, C., Murri, L., Ruggieri, S., Paparelli, A. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A, 2008; 105(6): 2052-2057.
90. Sarkar, S., Floto, R.A., Berger, Z., Imarisio, S., Cordenier, A., Pasco, M., Cook, L.J., Rubinsztein, D. C. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol, 2005; 170(7): 1101- 1111.
91. Springer, J. E., Azbill, R. D., Knapp, P. E. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat Med, 1999; 5(8): 943-946.
92. Penas, C., Guzman, M.S., Verdu, E., Fores, J., Navarro, X., Casas, C. Spinal cord injury induces endoplasmic reticulum stress with different cell-type dependent response. J Neurochem, 2007; 102(4): 1242- 1255.
93. Yamauchi, T., Sakurai, M., Abe, K., Matsumiya, G., Sawa, Y. Impact of the endoplasmic reticulum stress response in spinal cord after transient ischemia. Brain Res, 2007; 1169(24-33.
94. Prusiner, S.B. Prions. Proc Natl Acad Sci U S A, 1998; 95(23): 13363-13383.
95. Collinge, J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci, 2001; 24(519-550.
96. Budka, H., Aguzzi, A., Brown, P., Brucher, J. M., Bugiani, O., Gullotta, F., Haltia, M., Hauw, J. J., Ironside, J. W., Jellinger, K., et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol, 1995; 5(4): 459-466.
97. Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R.J., Cohen, F. E., et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A, 1993; 90(23): 10962-10966.
98. Vey, M., Pilkuhn, S., Wille, H., Nixon, R., DeArmond, S.J., Smart, E.J., Anderson, R. G., Taraboulos, A., Prusiner, S. B. Subcellular colocalization of the cellula and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A, 1996; 93(25): 14945-14949.
99. Hetz, C., Maundrell, K., Soto, C. Is loss of function of the prion protein the cause of prion disorders? Trends Mol Med, 2003; 9(6): 237-243.
100. Hetz, C., Soto, C. Protein misfolding and disease: the case of prion disorders. Cell Mol Life Sci, 2003; 60(1): 133-143.
101. Chiesa, R., Drisaldi, B., Quaglio, E., Migheli, A., Piccardo, P., Ghetti, B., Harris, D. A. Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc Natl Acad Sci U S A, 2000; 97(10): 5574-5579.
102. Ma, J., Wollmann, R., Lindquist, S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science, 2002; 298(5599): 1781-1785.
103. Supattapone, S., Bosque, P., Muramoto, T., Wille, H., Aagaard, C., Peretz, D., Nguyen, H. O., Heinrich, C., Torchia, M., Safar, J., Cohen, F. E., DeArmond, S. J., Prusiner, S. B., Scott, M. Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice. Cell, 1999; 96(6): 869- 878.
104. Supattapone, S., Bouzamondo, E., Ball, H.L., Wille,H., Nguyen, H.O., Cohen, F.E., DeArmond, S.J., Prusiner, S. B., Scott, M. A protease-resistant 61- residue prion peptide causes neurodegeneration in transgenic mice. Mol Cell Biol, 2001; 21(7): 2608- 2616.
105. Hetz, C., Lee, A. H., Gonzalez-Romero, D., Thielen, P., Castilla, J., Soto, C., Glimcher, L. H. Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis. Proc Natl Acad Sci U S A, 2008; 105(2): 757-762.
106. Steele, A. D., Hetz, C., Yi, C., Jackson, W., Borkowski, A., Yuan, J., Wollmann, R., Lindquist, S. Prion disease in caspase-12 knockout mice. Proc Natl Acad Sci U S A, 2008.
107. Brown, A.R., Rebus, S., McKimmie, C. S., Robertson, K., Williams, A., Fazakerley, J. K. Gene expression ofiling of the preclinical scrapie-infected hippocampus. Biochem Biophys Res Commun, 2005; 334(1): 86-95.
108. Rane, N.S., Kang, S.W., Chakrabarti, O., Feigenbaum, L., Hegde, R.S. Reduced translocation of nascent prion protein during ER stress contributes to neurodegeneration. Dev Cell, 2008; 15(3): 359-370.
109. Hetz, C., Russelakis-Carneiro, M., Walchli, S., Carboni, S., Vial-Knecht, E., Maundrell, K., Castilla, J., Soto, C. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci, 2005; 25(11): 2793-2802.
110. Hetz, C., Castilla, J., Soto, C. Perturbation of endoplasmic reticulum homeostasis facilitates prion ication. J Biol Chem, 2007; 282(17): 12725-12733.
111. Orsi, A., Fioriti, L., Chiesa, R., Sitia, R. Conditions ofendoplasmic reticulum stress favor the accumulation of cytosolic prion protein. J Biol Chem, 2006; 281(41): 30431-30438.
112. Apodaca, J., Kim, I., Rao, H. Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response. Biochem Biophys Res Commun, 2006; 347(1): 319-326.
113. Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., Aguzzi, A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature, 1996; 379(6563): 339-343.
114. Mallucci, G., Dickinson, A., Linehan, J., Klohn, P.C.,Brandner, S., Collinge, J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science, 2003; 302(5646): 871-874.
115. Mallucci, G.R., White, M.D., Farmer, M., Dickinson, A., Khatun, H., Powell, A.D., Brandner, S., Jefferys, J.G., Collinge, J. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron, 2007; 53(3): 325-335.
116. Hetz, C. A., Soto, C. Stressing out the ER: a role of the unfolded protein response in prion-related disorders. Curr Mol Med, 2006; 6(1): 37-43.
117. Steele, A.D., King, O.D., Jackson, W.S., Hetz, C.A., Borkowski, A.W., Thielen, P., Wollmann, R., Lindquist, S. Diminishing apoptosis by deletion of Bax or overexpression of Bcl-2 does not protect against infectious prion toxicity in vivo. J Neurosci, 2007; 27(47): 13022-13027.
118. Kristiansen, M., Messenger, M.J., Klohn, P.C., Brandner, S., Wadsworth, J.D., Collinge, J., Tabrizi, S. J. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. J Biol Chem, 2005; 280(46): 38851-38861.
119. Rubinsztein, D.C., Gestwicki, J.E., Murphy, L.O., Klionsky, D.J. Potential therapeutic applications of autophagy. Nat Rev Drug Discov, 2007; 6(4): 304-312.
120. Korth, C., May, B.C., Cohen, F.E., Prusiner, S.B. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci U S A, 2001; 98(17): 9836-9841.
121. Korth, C., Peters, P. J. Emerging pharmacotherapies for Creutzfeldt-Jakob disease. Arch Neurol, 2006; 63(4): 497-501.
122. Stewart, L.A., Rydzewska, L.H., Keogh, G.F., Knight, R.S. Systematic review of therapeutic interventions in human prion disease. Neurology, 2008; 70(15): 1272-1281.
123. Tatzelt, J., Prusiner, S.B., Welch, W.J. Chemical chaperones interfere with the formation of scrapie prion protein. Embo J, 1996; 15(23): 6363-6373.
124. Beranger, F., Crozet, C., Goldsborough, A., Lehmann,S. Trehalose impairs aggregation of PrPSc molecules and protects prion-infected cells against oxidative damage. Biochem Biophys Res Commun, 2008; 374(1): 44-48.
125. Cordeiro, Y., Lima, L.M., Gomes, M.P., Foguel, D., Silva, J.L. Modulation of prion protein oligomerization, aggregation, and beta-sheet conversion by 4,4'-dianilino-1,1'-binaphthyl-5,5'- sulfonate (bis-ANS). J Biol Chem, 2004; 279(7): 5346- 5352.
126. Soto, C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci, 2003; 4(1): 49-60.
127. Soto, C., Kascsak, R.J., Saborio, G. P., Aucouturier, P., Wisniewski, T., Prelli, F., Kascsak, R., Mendez, E., Harris, D. A., Ironside, J., Tagliavini, F., Carp, R. I., Frangione, B. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet, 2000; 355(9199): 192-197.
128. de Rijk, M.C., Launer, L.J., Berger, K., Breteler, M.M., Dartigues, J. F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martinez-Lage, J., Trenkwalder, C., Hofman, A. Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology, 2000; 54(11 Suppl 5): S21-23.
129. Klein, C., Lohmann-Hedrich, K. Impact of recent genetic findings in Parkinson's disease. Curr Opin Neurol, 2007; 20(4): 453-464.
130. Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C.M., Hill, K. J., Bhullar, B., Liu, K., Xu, K., Strathearn, K.E., Liu, F., Cao, S., Caldwell, K. A., Caldwell, G.A., Marsischky, G., Kolodner, R. D., Labaer, J., Rochet, J. C., Bonini, N. M., Lindquist, S. Alphasynuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science, 2006; 313(5785): 324-328.
131. Smith, W.W., Jiang, H., Pei, Z., Tanaka, Y., Morita, H., Sawa, A., Dawson, V.L., Dawson, T.M., Ross, C. A. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synucleininduced toxicity. Hum Mol Genet, 2005; 14(24): 3801- 3811.
132. Ryu, E. J., Harding, H. P., Angelastro, J. M., Vitolo, O. V., Ron, D., Greene, L. A. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci, 2002; 22(24): 10690-10698.
133. Holtz, W. A., O'Malley, K. L. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem, 2003; 278(21): 19367-19377.
134. Abou-Sleiman, P.M., Muqit, M.M., Wood, N. W. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci, 2006; 7(3): 207-219.
135. Wang, H.Q., Takahashi, R. Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease. Antioxid Redox Signal, 2007; 9(5): 553-561.
136. Lee, A.H., Iwakoshi, N.N., Glimcher, L.H. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol, 2003; 23(21): 7448-7459.
137. Kakiuchi, C., Iwamoto, K., Ishiwata, M., Bundo, M., Kasahara, T., Kusumi, I., Tsujita, T., Okazaki, Y., Nanko, S., Kunugi, H., Sasaki, T., Kato, T. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet, 2003; 35(2): 171-175.
138. Chen, W., Duan, S., Zhou, J., Sun, Y., Zheng, Y., Gu, N., Feng, G., He, L. A case-control study provides evidence of association for a functional polymorphism -197C/G in XBP1 to schizophrenia and suggests a sexdependent effect. Biochem Biophys Res Commun, 2004; 319(3): 866-870.
139. Kusumi, I., Masui, T., Kakiuchi, C., Suzuki, K., Akimoto, T., Hashimoto, R., Kunugi, H., Kato, T., Koyama, T. Relationship between XBP1 genotype and personality traits assessed by TCI and NEO-FFI. Neurosci Lett, 2005; 391(1-2): 7-10.
140. Kusumi, I., Masui, T., Kakiuchi, C., Suzuki, K., Akimoto, T., Hashimoto, R., Kunugi, H., Kato, T., Koyama, T. Relationship between XBP1 genotype and personality traits assessed by TCI and NEO-FFI. Neurosci Lett, 2005; 391(1-2): 7-10.
141. Zhao, L., Longo-Guess, C., Harris, B. S., Lee, J. W., Ackerman, S. L. Protein accumulation and neurodegeneration in the woozy mutant mouse is caused by disruption of SIL1, a cochaperone of BiP. Nat Genet, 2005; 37(9): 974-979.